Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Rat (Rattus) SEMA4D Antikörper:
anti-Human SEMA4D Antikörper:
anti-Mouse (Murine) SEMA4D Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Monoclonal SEMA4D Primary Antibody für FACS - ABIN610341
Drivas, Shih, Coutavas, Rush, DEustachio: Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line. in Molecular and cellular biology 1990
Show all 2 Pubmed References
Rat (Rattus) Polyclonal SEMA4D Primary Antibody für IF/ICC, IHC - ABIN2910752
Zhou, Li, Jin, Wu, He, Wang, Lei, Hu: Sema4D/PlexinB1 inhibition ameliorates blood-brain barrier damage and improves outcome after stroke in rats. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2018
Human Monoclonal SEMA4D Primary Antibody für ELISA, WB - ABIN564579
Luque, Gutierrez, Debbas, Martins, Puech-Leao, Porto, Coelho, Boumsell, Kalil, Stolf: Phage display identification of CD100 in human atherosclerotic plaque macrophages and foam cells. in PLoS ONE 2013
Cynomolgus Monoclonal SEMA4D Primary Antibody für FACS, IP - ABIN2477980
Senn, Jungi: Neutrophil migration in health and disease. in Seminars in hematology 1975
Show all 2 Pubmed References
Cynomolgus Monoclonal SEMA4D Primary Antibody für FACS - ABIN2477983
Mizrahi, Markel, Porgador, Bushkin, Mandelboim: CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72. in PLoS ONE 2007
Show all 2 Pubmed References
knockdown of Sema4D in Head and neck squamous cell carcinomas (HNSCCs)cells inhibited tumor growth and decreased the number of osteoclasts in a mouse xenograft model. Taken together, IGF-I (zeige IGF1 Antikörper)-driven production of Sema4D in HNSCCs promotes osteoclastogenesis and bone invasion.
describe the transfection, purification, and visualization of Fc-tagged SEMA4D (semaphorin 4D) recombinant protein
describe the application of in vitro migration and tubulogenesis assays and the directed in vivo angiogenesis assay (DIVAA) in the measurement of the angiogenic potential of cell-derived and soluble SEMA4D
The positive expression of both Sema4D and PlexinB1 (zeige PLXNB1 Antikörper) was found to be an independent risk factor for a worse survival in colorectal cancer.
Serum levels of soluble SEMA4D were elevated in patients with ANCA-associated vasculitis. Cell-surface expression of SEMA4D was downregulated, a consequence of proteolytic cleavage of membrane SEMA4D. Soluble SEMA4D exerted pro-inflammatory effects on endothelial cells. Membranous SEMA4D on neutrophils bound to plexin B2 on endothelial cells, and this interaction decreased NET formation.
We identified a novel genome-wide significant African-specific locus for BMI (SEMA4D, rs80068415). A novel variant in SEMA4D was significantly associated with body mass index. Carriers of the C allele were 4.6 BMI units heavier than carriers of the T allele.
A critical pathogenic engagement of Semaphorin 4D produced by gamma delta T cells in the development of medication-related osteonecrosis of the jaw
Our results identified FGL2 (zeige FGL2 Antikörper), GAL (zeige GAL Antikörper), SEMA4D, SEMA7A (zeige SEMA7A Antikörper), and IDO1 (zeige IDO1 Antikörper) as new candidate genes that could be involved in MSCs-mediated immunomodulation. FGL2 (zeige FGL2 Antikörper), GAL (zeige GAL Antikörper), SEMA4D, SEMA7A (zeige SEMA7A Antikörper), and IDO1 (zeige IDO1 Antikörper) genes appeared to be differentially transcribed in the different MSC (zeige MSC Antikörper) populations. Moreover, these genes were not similarly modulated following MSCs-exposure to inflammatory signals
Interferon-alpha (zeige IFNA Antikörper)-induced CD100 expression on naive CD8 (zeige CD8A Antikörper)(+) T cells enhances antiviral responses to hepatitis C infection through CD72 (zeige CD72 Antikörper) signal transduction.
In this review, we summarized the current findings on neuroimmune Sema4A (zeige Sema4a Antikörper) and Sema4D molecules in chronic inflammation underlying many diseases and discussed their positive or negative impacts on the implicated molecular and cellular processes
These results reveal a novel signaling network, the Sema4D-RhoA (zeige RHOA Antikörper)-Akt (zeige AKT1 Antikörper) signal cascade, that coordinates cellular function and morphology and highlights the importance of specific spatiotemporally restricted components of a signaling pathway in the regulation of ameloblast differentiation.
our findings revealed for the first time that Sema4D positively regulated both the adaptive and innate immune responses in contact hypersensitivity
SEMA4D-/- neutrophils show impaired NET formation when in contact with endothelial cells.
Absence of Sema4D improves oligodendrocyte recovery after cerebral ischemia/reperfusion injury in mice
Sema4D-deficiency affected ischemia-induced microglial activation in morphology, iNOS (zeige NOS2 Antikörper) expression, and proliferation, and this deficiency most likely resulted in moderation of cytotoxicity and locomotor behavioral abnormality after cerebral ischemia
The addition of recombinant Sema4D to Sema4D/ vaginal epithelial cells in culture significantly enhanced apoptosis of the vaginal epithelial cells.
Sema4D may be an essential apoptosis-inducing ligand that acts downstream of estrogen action in vaginal epithelium during pubertal tissue remodeling.
therapeutic effects via bone-targeting systems featuring interference of Sema4d are able to partly counteract alveolar bone loss caused by osteoporosis.
CD100-mediated signals are critical for effective activation of gammadelta IEL to produce growth factors, including KGF (zeige FGF7 Antikörper)-1, that are required for healing of the colon epithelium during colitis.
Deletion of plexin-B1 (zeige PLXNB1 Antikörper), the high affinity receptor for semaphorin 4D, significantly (one-way ANOVA; p < 0.001) reduced thrombus weight (- 40%) in oxidative venous thrombosis.
Cell surface receptor for PLXN1B and PLXNB2 that plays an important role in cell-cell signaling. Promotes reorganization of the actin cytoskeleton and plays a role in axonal growth cone guidance in the developing central nervous system. Regulates dendrite and axon branching and morphogenesis. Promotes the migration of cerebellar granule cells and of endothelial cells. Plays a role in the immune system\; induces B-cells to aggregate and improves their viability (in vitro). Promotes signaling via SRC and PTK2B/PYK2, which then mediates activation of phosphatidylinositol 3-kinase and of the AKT1 signaling cascade. Interaction with PLXNB1 mediates activation of RHOA (By similarity).
, sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4D
, M-sema G
, sema J
, semaphorin H
, semaphorin-C-like 2
, semaphorin 4D